基于天然生物聚合物的CRISPR/Cas9输送用于癌症治疗
1Department of Pharmacy, West China Hospital, Sichuan University, Chengdu 610041, China.
Pharmaceutics
|January 23, 2024
概括
自然生物聚合物为提供CRISPR/Cas9基因编辑工具提供了一个有前途的解决方案,增强癌症治疗. 这些材料提高了稳定性和效率,克服了临床应用的关键交付挑战.
科学领域:
- 生物材料科学 生物材料科学
- 基因编辑技术 基因编辑技术
- 癌症治疗方法 癌症治疗方法
背景情况:
- 聚类,定期间隔的短平行列重复 (CRISPR) /CRISPR相关蛋白9 (Cas9) 系统是治疗疾病,特别是癌症的领先基因编辑工具.
- 有效地传递CRISPR/Cas9 (作为DNA,mRNA或核糖蛋白) 仍然是临床翻译的一个重大障碍.
- 纳米材料正在开发中,以提高CRISPR/Cas9系统的稳定性和传递效率.
研究的目的:
- 审查基于天然生物聚合物的材料在癌症治疗中用于CRISPR/Cas9传递的进展.
- 突出自然生物聚合物的优点,包括稳定性,低毒性和生物相容性.
- 讨论与这些传递系统的临床翻译相关的挑战.
主要方法:
- 文献综述侧重于用于CRISPR/Cas9传递的天然生物聚合物应用.
- 对基因编辑传递 (稳定性,毒性,生物相容性) 有关材料性质的分析.
- 检查专门针对癌症应用的研究.
主要成果:
- 自然生物聚合物显示出作为CRISPR/Cas9系统的载体的巨大潜力.
- 与其他输送方法相比,这些材料提供了更好的稳定性,生物相容性和生物降解性.
- 在临床前癌症模型中报告了成功的应用.
结论:
- 基于天然生物聚合物的载体代表了在癌症治疗中推进CRISPR/Cas9基因编辑的有希望的策略.
- 克服交付挑战对于实现CRISPR/Cas9.9的全部临床潜力至关重要.
- 需要进一步的研究来解决成功临床翻译的剩余挑战.
相关概念视频
CRISPR
51.1K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
51.1K
CRISPR and crRNAs
17.0K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.0K


